View Author
scopus: 6602110689

Kate, M.T. ten

(Marian ten Kate)


treatment infection liposomes concentration blood study agent model survival ef ficacy ciprofloxacin result animal agents chemother antimicrob number chemother ambisome inoculation pl cipro pneumoniae effect liposomal administration therapy lipid ficacy cloacae efficacy strain bacteria antibiotic combination pharmacokinetic mutant aeruginosa activity dosage clearance cipro aspergillosi caspofungin resistance tissue amikacin anti-tb drugs antifungal le-gen ceftazidime patient level isoniazid pneumonia liposome amphotericin control toxicity cloacae mutants mycobacteria antimicrobial 5 days time points selection value signi parameter 6 days 10 mg /kg ratio bakker-woudenberg right lung 10 days ceftazidime-resistant e rifampicin circulation increase serum delivery signi ficantly anti-tb




10 Most Recent Publications

Relapse of tuberculosis versus primary tuberculosis; Course, pathogenesis and therapy in mice (Article)
Steenwinkel, J.E.M. de Knegt, G.J. de Kate, M.T. ten Verbrugh, H.A. Hernandez-Pando, R. Leenen, P.J.M. Bakker-Woudenberg, I.A.J.M.
2013-03-01
Dynamics of interferon-gamma release assay and cytokine profiles in blood and respiratory tract specimens from mice with tuberculosis and the effect of therapy (Article)
Steenwinkel, J.E.M. de Knegt, G.J. de Kate, M.T. ten Verbrugh, H.A. Ottenhoff, T.H.M. Bakker-Woudenberg, I.A.J.M.
2011-10-07
Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis (Article)
Steenwinkel, J.E.M. de Knegt, G.J. de Kate, M.T. ten Belkum, A.F. van Verbrugh, H.A. Kremer, K. Soolingen, D. van Bakker-Woudenberg, I.A.J.M.
2010-12-01
Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin (Article)
Sande, W.W.J. van de Mathot, R.A.A. Kate, M.T. ten Vianen, W. van Tavakol, M. Rijnders, B.J.A. Bakker-Woudenberg, I.A.J.M.
2009-05-01
Caspofungin prolongs survival of transiently neutropenic rats with advanced-stage invasive pulmonary aspergillosis (Article)
Sande, W.W.J. van de Vianen, W. van Kate, M.T. ten Vissers, J. Laurijsens, J. Tavakol, M. Rijnders, B.J.A. Mathot, R.A. Bakker-Woudenberg, I.A.J.M.
2008-04-01
Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice (Article)
Steenwinkel, J.E.M. de Vianen, W. van Kate, M.T. ten Verbrugh, H.A. Agtmael, M.A. van Schiffelers, R.M. Bakker-Woudenberg, I.A.J.M.
2007-11-01
Role of ceftazidime dose regimen on the selection of resistant Enterobacter cloacae in the intestinal flora of rats treated for an experimental pulmonary infection (Article)
Goessens, W.H.F. Mouton, J.W. Kate, M.T. ten Bijl, A.J. Ott, A. Bakker-Woudenberg, I.A.J.M.
2007-03-01
Ciprofloxacin in polyethylene glycol-coated liposomes: efficacy in rat models of acute or chronic Pseudomonas aeruginosa infection (Article)
Bakker-Woudenberg, I.A.J.M. Kate, M.T. ten Guo, L. Working, P. Mouton, J.W.
2002-01-01
Improved efficacy of ciprofloxacin administered in polyethylene glycol-coated liposomes for treatment of Klebsiella pneumoniae pneumonia in rats. (Article)
Bakker-Woudenberg, I.A.J.M. Kate, M.T. ten Guo, L. Working, P. Mouton, J.W.
2001-05-07
Therapeutic efficacy of liposome-encapsulated gentamicin in rat Klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin. (Article)
Schiffelers, R.M. Storm, G. Kate, M.T. ten Bakker-Woudenberg, I.A.J.M.
2001-02-08